Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | CES2 | O00748 | 2/20 | 0.44 |
| ▸ | CES1 | P23141 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | GSK3B | P49841 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.40 |
| ▸ | ACHE | P22303 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | PKM | P14618 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 2/20 | 0.39 |
| ▸ | ATM | Q13315 | 2/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | NLRP1 | Q9C000 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2263489 | 0.89 | NR1I2 (0.42) | ALDH1A1LMNASMN1; SMN2ACHEKMT2A | |
| SCHEMBL16442727 | 0.88 | MMP13 (0.49) | ALDH1A1LMNASMN1; SMN2TDP1KMT2A | |
| SCHEMBL8410387 | 0.85 | SLC6A4 (0.36) | ALDH1A1LMNASMN1; SMN2ACHEKMT2A | |
| SCHEMBL7197697 | 0.81 | ALDH1A1 (0.41) | ALDH1A1LMNACES2CES1SMN1; SMN2 | |
| SCHEMBL295411 | 0.80 | ALDH1A1 (0.44) | ALDH1A1LMNACES2CES1SMN1; SMN2 | |
| SCHEMBL5749794 | 0.80 | ESR1 (0.58) | ALDH1A1LMNASMN1; SMN2TDP1ACHE | |
| SCHEMBL28445165 | 0.80 | GSK3B (0.58) | ALDH1A1LMNACES2CES1SMN1; SMN2 | |
| SCHEMBL5178198 | 0.78 | MAOA (0.47) | ALDH1A1CES2CES1SMN1; SMN2GSK3B | |
| SCHEMBL11698205 | 0.78 | CYP19A1 (0.54) | ALDH1A1LMNATDP1KMT2AMEN1 | |
| SCHEMBL2015853 | 0.78 | MAOA (0.55) | ALDH1A1LMNACES2CES1GSK3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114874392-A | Preparation method of ACS resin | 长春工业大学 | 2022-08-09 | — | — | CN | claimed |
| US-6534595-B2 | Blend of thermosetting resin, decomposable resin and solvent | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-03-18 | — | — | US | claimed |
| US-20010038887-A1 | Coating solution for forming porous organic film | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-11-08 | — | — | US | claimed |
| US-4956123-A | REACTING A STYRENE TYPE COMPOUND WITH A DIHALOACYL PEROXIDE TO MAKE A FLUOROALKYLAROMATIC ESTER | NIPPON OILS & FATS COMPANY, LTD. (JP) | 1990-09-11 | — | — | US | claimed |
| EP-0189275-B1 | METHOD FOR MANUFACTURE OF FLUORINE-CONTAINING AROMATIC DERIVATIVES | NIPPON OIL AND FATS COMPANY, LIMITED (JP) | 1989-10-18 | — | — | EP | claimed |
| US-4709109-A | Preparation of alkenylaromatics | BASF AKTIENGESELLSCHAFT (DE) | 1987-11-24 | — | — | US | claimed |
| EP-0189275-A2 | Method for manufacture of fluorine-containing aromatic derivatives | NIPPON OIL AND FATS COMPANY, LIMITED (JP) | 1986-07-30 | — | — | EP | claimed |
| CN-114874392-A | Preparation method of ACS resin | 长春工业大学 | 2022-08-09 | — | — | CN | disclosed |
| EP-2984055-B1 | PREPARATION OF SURFACTANTS VIA CROSS-METATHESIS | MATERIA INC (US) | 2018-10-17 | — | — | EP | disclosed |
| US-9758445-B2 | Preparation of surfactants via cross-metathesis | MATERIA, INC. (US) | 2017-09-12 | — | — | US | disclosed |
| US-9663459-B2 | Preparation of surfactants via cross-metathesis | MATERIA, INC. (US) | 2017-05-30 | — | — | US | disclosed |
| US-20160186094-A1 | PREPARATION OF SURFACTANTS VIA CROSS-METATHESIS | MATERIA, INC. | 2016-06-30 | — | — | US | disclosed |
| US-20160145204-A1 | PREPARATION OF SURFACTANTS VIA CROSS-METATHESIS | MATERIA, INC. | 2016-05-26 | — | — | US | disclosed |
| EP-0219092-A1 | Process for preparing alkenylaromatic compounds | BASF Aktiengesellschaft (DE) | 1987-04-22 | — | — | EP | disclosed |
| EP-0189275-A2 | Method for manufacture of fluorine-containing aromatic derivatives | NIPPON OIL AND FATS COMPANY, LIMITED (JP) | 1986-07-30 | — | — | EP | disclosed |
| US-4598124-A | GRAFT POLYMERIZATION | MONSANTO COMPANY (US) | 1986-07-01 | — | — | US | disclosed |
| US-4417030-A | SEPARATELY CHARGING RUBBER DISSOLVED IN ALKENYL AROMATIC MONOMER AND ALKENYL NITRILE | MONSANTO COMPANY (US) | 1983-11-22 | — | — | US | disclosed |
| EP-0067536-A1 | Mass polymerization process for ABS polyblends | MONSANTO COMPANY (US) | 1982-12-22 | — | — | EP | disclosed |
| US-4198535-A | HEATING WITH SILICA-ALUMINA CATALYST | MITSUI PETROCHEMICAL INDUSTRIES LTD. (JP) | 1980-04-15 | — | — | US | disclosed |
| US-3946081-A | OXIDATION CATALYSTS, GROUP V, VI, OR VII OXIDES | BAYER AKTIENGESELLSCHAFT (DT) | 1976-03-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160186094-A1 | PREPARATION OF SURFACTANTS VIA CROSS-METATHESIS | SMURF2, EPHX2, SMURF1 | ALDH1A1 1887/4885LMNA 1872/4885CES2 249/4885 |
| US-20160145204-A1 | PREPARATION OF SURFACTANTS VIA CROSS-METATHESIS | SMURF2, SMURF1, ABCB4 | ALDH1A1 3135/4885LMNA 1327/4885CES2 378/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.